What are the recommended next diagnostic and management steps for a 34‑year‑old woman with Ehlers‑Danlos syndrome, mast cell activation syndrome, postural orthostatic tachycardia syndrome, mildly low IgG/IgM/IgA levels, recurrent ear and respiratory infections, persistent lingual papillitis and aphthous ulcers, non‑immune measles and mumps despite two MMR doses, high hepatitis B surface antibody, early degenerative spinal changes, prior rib fracture, cholecystectomy with adhesions, past eosinophilia, severe EBV infection, and prior tonsillectomy?

Next Steps for a Patient with hEDS, MCAS, POTS, and Abnormal Immunoglobulin Findings

This patient requires formal immunology evaluation for possible antibody deficiency disorder, given low IgG/IgM/IgA levels, recurrent infections, and failure to mount protective vaccine responses despite documented immunization. 1

Immediate Priority: Immunology Referral and Testing

Essential Immunologic Work-Up

• Measure vaccine-specific antibody titers to assess functional antibody production: pneumococcal polysaccharide (23-valent), tetanus, diphtheria, and confirm the documented measles/mumps non-immunity. 1

• Obtain complete lymphocyte subset analysis (CD3, CD4, CD8, CD19, CD16/56) to evaluate for combined immunodeficiency or B-cell dysfunction. 1

• Repeat quantitative immunoglobulins (IgG, IgA, IgM, IgE) with IgG subclasses (IgG1-4) to characterize the pattern of deficiency more precisely. 1

• Measure baseline serum tryptase given her documented MCAS symptoms and multisystem involvement (recurrent infections, oral ulcers, prior eosinophilia), but only because she meets criteria for episodic multisystem symptoms. 2, 1

Critical Context for Immunology Referral

• The combination of low IgG (812 mg/dL), low IgM (69 mg/dL), and borderline-low IgA (79 mg/dL) with recurrent sinopulmonary infections and documented vaccine failure (non-immune to measles/mumps after two MMR doses) strongly suggests Common Variable Immunodeficiency (CVID) or specific antibody deficiency. 1

• The paradoxically high hepatitis B surface antibody (>1000) after only two doses is unusual and may represent polyclonal B-cell activation or dysregulated antibody production, which can occur in immunodeficiency states. 1

Secondary Priority: Confirm MCAS Diagnosis

MCAS Diagnostic Testing

• Collect repeat serum tryptase during a symptomatic flare (within 1-4 hours of symptoms) and compare to baseline; diagnostic threshold requires 20% increase above baseline plus 2 ng/mL. 2, 1

• Refer to allergy/immunology or mast cell disease research center for comprehensive MCAS evaluation, as her symptoms (recurrent infections, oral ulcers, prior eosinophilia, dramatic response to antihistamine regimen) suggest true MCAS rather than isolated histamine intolerance. 2, 1

Why This Matters

• Up to 31% of patients with both POTS and hEDS have concurrent MCAS, making this a high-yield evaluation. 3

• Her dramatic symptom improvement with Zyrtec BID, Pepcid BID, and quercetin supports mast cell involvement but does not confirm MCAS diagnosis without laboratory criteria. 2

Tertiary Priority: Address Recurrent Oral Lesions

Differential Diagnosis for Transient Lingual Papillitis and Aphthous Ulcers

• Screen for celiac disease with tissue transglutaminase IgA and total IgA (already documented as low), as celiac disease risk is elevated in hEDS patients and can present with recurrent oral ulcers. 2, 1

• Consider Behçet's disease or other autoinflammatory conditions if oral ulcers persist despite MCAS treatment optimization; obtain HLA-B51 if clinical suspicion is high. 1

• Evaluate for nutritional deficiencies (vitamin B12, folate, iron, zinc) that commonly cause recurrent aphthous ulcers, especially in the context of possible malabsorption from immunodeficiency or celiac disease. 1

Cardiovascular Surveillance (Ongoing)

• Obtain baseline echocardiogram to assess aortic root diameter, as 25-33% of hypermobile EDS patients develop aortic dilation. 1, 4

• Repeat echocardiography every 2-3 years if aortic root is normal, or every 6 months if diameter exceeds 4.5 cm or growth rate exceeds 0.5 cm/year. 1, 4

Gastrointestinal Evaluation (If Symptoms Present)

• Perform anorectal manometry, balloon expulsion test, or defecography if she reports incomplete evacuation or constipation, given the 50% prevalence of pelvic floor dysfunction in hEDS. 2, 1

• Consider gastric emptying study if she develops chronic nausea, vomiting, or early satiety, as gastroparesis is more common in hEDS patients with comorbid POTS. 2, 1

Common Pitfalls to Avoid

• Do not dismiss low immunoglobulin levels as "borderline" or "within normal variation" when combined with recurrent infections and vaccine failure—this pattern warrants formal immunology evaluation. 1

• Do not perform universal MCAS testing in all hEDS patients; testing should be targeted to those with episodic multisystem symptoms (which this patient has). 2, 1

• Do not attribute all symptoms to MCAS or POTS without excluding treatable conditions like celiac disease, immunodeficiency, or nutritional deficiencies. 2, 1

• Avoid invasive procedures (e.g., colonoscopy, upper endoscopy) unless clearly indicated, as hEDS patients have increased risk of complications from tissue fragility. 1, 5

Practical Management Algorithm

Time Frame	Action	Rationale
Week 1	Refer to immunology; order vaccine titers, lymphocyte subsets, IgG subclasses, celiac panel	Establish if immunodeficiency explains recurrent infections and vaccine failure [1]
Week 2	Obtain baseline tryptase; schedule repeat during next symptomatic flare	Confirm MCAS diagnosis with laboratory criteria [2,1]
Week 3	Order baseline echocardiogram	Screen for aortic root dilation (25-33% prevalence in hEDS) [1,4]
Month 2	Review all results with immunology; consider IVIG if functional antibody deficiency confirmed	Prevent recurrent infections and improve quality of life [1]
Month 3	Refer to allergy/mast cell center if MCAS confirmed; optimize antihistamine regimen	Specialized MCAS management beyond H1/H2 blockade [2,1]

Multidisciplinary Coordination

• Primary coordinator: Gastroenterology or primary care can coordinate initial work-up, as gastroenterologists are well-positioned to screen for hEDS, POTS, and MCAS simultaneously. 6

• Essential specialists: Immunology (for antibody deficiency), allergy/immunology (for MCAS), cardiology (for POTS and aortic surveillance), medical genetics (for formal hEDS diagnosis confirmation). 1, 6

• Avoid fragmented care: Ensure all specialists communicate findings, as the triad of hEDS/POTS/MCAS plus immunodeficiency creates complex interactions requiring integrated management. 6, 3